Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. M3, Inc.
  6. News
  7. Summary
    2413   JP3435750009

M3, INC.

(2413)
  Report
End-of-day quote. End-of-day quote Japan Exchange - 08/04
7031 JPY   -1.39%
07/28M3 : Presentation Material
PU
07/28M3 : Presentation Material
PU
07/28M3 : Consolidated Financial Results for the Three Months Ended June 30, 2021
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medlive Technology Advances Plans for Hong Kong IPO

06/22/2021 | 03:24am EDT

By Ben Otto

Medlive Technology Co., an online medical information and marketing platform, is advancing plans for an initial public offering in Hong Kong, joining the growing list of Chinese healthcare-focused companies seeking to tap into bullish sentiment in the Asian financial hub.

The Beijing-based online platform intends to use the proceeds to expand its business, invest in technology and make strategic investments or acquisitions, it said in a filing to the Hong Kong bourse Tuesday. It didn't specify a timeline for the offering or the amount it planned to raise.

Medlive operates China's largest online platform for doctors by number of registered physician users, it said in a draft prospectus, citing industry consultancy Frost & Sullivan. Its users include some 2.4 million licensed physicians, who can use the platform to access content including research articles, clinical guides and drug references.

The company generates revenue primarily from marketing services to pharmaceutical and medical device companies using the platform. Its major shareholders include Tokyo-based M3 Inc., an online medical services provider and an affiliate of Sony Group Corp.

Medlive's listing plans come as a number of Chinese healthcare-focused startups are seeking to go public. Biotech companies Transcenta Holding Ltd., Brii Biosciences and Keymed Biosciences Inc. filed IPO documents this week. These filings come close on the heels of companies ranging from hair transplant specialist Yonghe Medical Group to teeth alignment company Angelalign Technology Inc., which raised about US$350 million in an IPO last week.

Medlive reported a net profit of 85.2 million yuan (US$13.2 million) in 2020 and CNY213.5 million revenue.

Goldman Sachs and Haitong International Capital are acting as joint sponsors for the planned IPO.

Write to Ben Otto at ben.otto@wsj.com

(END) Dow Jones Newswires

06-22-21 0323ET

Stocks mentioned in the article
ChangeLast1st jan.
M3, INC. -1.39% 7031 End-of-day quote.-27.84%
SONY GROUP CORPORATION -3.23% 11075 End-of-day quote.7.68%
All news about M3, INC.
07/28M3 : Presentation Material
PU
07/28M3 : Presentation Material
PU
07/28M3 : Consolidated Financial Results for the Three Months Ended June 30, 2021
PU
07/28M3, Inc. Announces Consolidated Earnings Results for the First Quarter Ended ..
CI
07/15M3 : Recognition of Dilution Gains from Changes in Equity Interest Mainly Relate..
PU
07/01M3 : Capital Alliance with Epigno Co., Ltd ~ Accelerate DX of Talent Management ..
PU
06/29Medlive Technology Plans to Raise Up to US$543 Million in Hong Kong IPO
DJ
06/28Japan's Nikkei ends flat as investors cautious ahead of U.S. data
RE
06/27Japan's Nikkei inches lower as chip-related stocks slip
RE
06/24M3 : Pfizer On-boards Entire Sales Rep Force onto M3's myMR-kun ~ Two-Way Digita..
PU
More news
Financials
Sales 2022 208 B 1 895 M 1 895 M
Net income 2022 59 935 M 547 M 547 M
Net cash 2022 128 B 1 167 M 1 167 M
P/E ratio 2022 79,6x
Yield 2022 0,23%
Capitalization 4 765 B 43 490 M 43 483 M
EV / Sales 2022 22,3x
EV / Sales 2023 18,8x
Nbr of Employees 8 249
Free-Float 60,2%
Chart M3, INC.
Duration : Period :
M3, Inc. Technical Analysis Chart | 2413 | JP3435750009 | MarketScreener
Technical analysis trends M3, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 7 031,00 JPY
Average target price 9 023,08 JPY
Spread / Average Target 28,3%
EPS Revisions
Managers and Directors
Itaru Tanimura President & Representative Director
Ryoko Toyama Independent Outside Director
Kenichiro Yoshida Outside Director
Akihiko Tomaru Director
Akinori Urae Director
Sector and Competitors
1st jan.Capi. (M$)
M3, INC.-27.84%43 558
ALPHABET INC.54.77%1 807 694
FACEBOOK INC31.40%1 011 955
TENCENT HOLDINGS LIMITED-19.01%559 170
ALIBABA GROUP HOLDING LIMITED-13.76%545 566
VISA8.20%503 354